Mayeta Clark 2015

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria

September 6, 2022

Background: Circulating myeloid-derived-suppressor-cells (MDSC) with immunosuppressive function are increased in human experimental Plasmodium falciparum infection, but have not been studied…

Read More

Induction, decay and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children

August 25, 2022

Background RTS,S is the first malaria vaccine recommended for implementation among young children at risk. However, vaccine efficacy is modest…

Read More

Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia

August 24, 2022

Background Understanding the effect of immunity on Plasmodium falciparum clearance is essential for interpreting therapeutic efficacy studies designed to monitor…

Read More

Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity

August 9, 2022

A more sensitive surveillance tool is needed to identify Plasmodium vivax infections for treatment and to accelerate malaria elimination efforts….

Read More

Pregnancy and Malaria: The perfect storm

July 25, 2022

Purpose of review: Malaria in pregnancy continues to exert a toll on pregnant women and their offspring. Recent findings: The burden of…

Read More

Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh

July 14, 2022

Background Malaria remains endemic in Bangladesh, with the majority of cases occurring in forested, mountainous region in the Chittagong Hill…

Read More

A Multiscale Mathematical Model of Plasmodium Vivax Transmission

July 1, 2022

Malaria is caused by Plasmodium parasites which are transmitted to humans by the bite of an infected Anopheles mosquito. Plasmodium…

Read More

Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity

June 23, 2022

Plasmodium vivax is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of…

Read More

Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial

June 8, 2022

Background In Papua (Indonesia), infants with P. falciparum and/or P. vivax malaria are at risk of severe anaemia and death. We hypothesized that in…

Read More

Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas – a radomised controlled trial

May 18, 2022

Background Plasmodium vivax forms dormant liver stages that can reactivate weeks or months following an acute infection. Recurrent infections are…

Read More

1 2 3 4 18